To verify this result in vivo, we established orthotopic HCC mouse models bearing Tnks1bp1 knockdown or control cells and treated the mice using an anti-PD-L1 mAb or IgG2a (Fig. 7G). The gene discussed is CNOT12; the disease is hepatocellular carcinoma.